£11.76
1.73%
London, Sep 29, 04:36 pm BST. Closed.
ISIN
GB00B0YD2B94
Symbol
CHRT

Cohort Target price 2026 - Analyst rating & recommendation

Cohort Classifications & Recommendation

Buy
83%
Hold
17%

Cohort Price Target

Target Price £16.73
Price £11.76
Potential
Number of Estimates 9
9 Analysts have issued a price target Cohort 2027 . The average Cohort target price is £16.73. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 10 Analysts recommend Cohort to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cohort stock has an average upside potential 2027 of . Most analysts recommend the Cohort stock at Purchase.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Apr '26 2027
Estimates
Revenue Million £ 306.39 329.25
13.46% 7.46%
EBITDA Margin 13.05% 15.52%
20.93% 18.97%
Net Margin 7.80% 9.69%
9.43% 24.22%

10 Analysts have issued a sales forecast Cohort 2027 . The average Cohort sales estimate is

£329m
unlock
. This is
7.46% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
£347m 13.33%
unlock
, the lowest is
£317m 3.31%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 £306m 13.46%
2027
£329m 7.46%
unlock
2028
£353m 7.13%
unlock
2029
£382m 8.33%
unlock

8 Analysts have issued an Cohort EBITDA forecast 2027. The average Cohort EBITDA estimate is

£51.1m
unlock
. This is
27.86% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
£54.6m 36.60%
unlock
, the lowest is
£48.1m 20.39%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 £40.0m 37.21%
2027
£51.1m 27.86%
unlock
2028
£56.6m 10.84%
unlock
2029
£63.4m 11.97%
unlock

EBITDA Margin

2026 13.05% 20.93%
2027
15.52% 18.97%
unlock
2028
16.06% 3.48%
unlock
2029
16.60% 3.36%
unlock

10 Cohort Analysts have issued a net profit forecast 2027. The average Cohort net profit estimate is

£31.9m
unlock
. This is
33.47% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
£35.4m 48.08%
unlock
, the lowest is
£29.5m 23.60%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 £23.9m 24.16%
2027
£31.9m 33.47%
unlock
2028
£36.1m 13.10%
unlock
2029
£41.0m 13.64%
unlock

Net Margin

2026 7.80% 9.43%
2027
9.69% 24.22%
unlock
2028
10.23% 5.57%
unlock
2029
10.73% 4.89%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Apr '26 2027
Estimates
Earnings Per Share £ 0.51 0.68
15.91% 33.33%
P/E 17.04
EV/Sales 1.64

10 Analysts have issued a Cohort forecast for earnings per share. The average Cohort EPS is

£0.68
unlock
. This is
33.33% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
£0.75 47.06%
unlock
, the lowest is
£0.63 23.53%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 £0.51 15.91%
2027
£0.68 33.33%
unlock
2028
£0.77 13.24%
unlock
2029
£0.87 12.99%
unlock

P/E ratio

Current 22.67 26.34%
2027
17.04 24.82%
unlock
2028
15.06 11.62%
unlock
2029
13.26 11.95%
unlock

Based on analysts' sales estimates for 2027, the Cohort stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.76 22.12%
2027
1.64 6.89%
unlock
2028
1.53 6.66%
unlock
2029
1.41 7.69%
unlock

P/S ratio

Current 1.74 22.61%
2027
1.62 6.94%
unlock
2028
1.51 6.66%
unlock
2029
1.39 7.69%
unlock

Current Cohort Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Berenberg Bank
Locked
➜
Locked
Locked Jul 21 2026
RBC Capital Markets
Locked
➜
Locked
Locked Jul 17 2026
Jefferies
Locked
➜
Locked
Locked Jul 01 2026
Jefferies
Locked
➜
Locked
Locked May 28 2026
RBC Capital Markets
Locked
➜
Locked
Locked May 28 2026
Shore Capital
Locked
➜
Locked
Locked Jul 16 2025
Shore Capital
Locked
➜
Locked
Locked May 29 2025
Analyst Rating Date
Locked
Berenberg Bank:
Locked
➜
Locked
Jul 21 2026
Locked
RBC Capital Markets:
Locked
➜
Locked
Jul 17 2026
Locked
Jefferies:
Locked
➜
Locked
Jul 01 2026
Locked
Jefferies:
Locked
➜
Locked
May 28 2026
Locked
RBC Capital Markets:
Locked
➜
Locked
May 28 2026
Locked
Shore Capital:
Locked
➜
Locked
Jul 16 2025
Locked
Shore Capital:
Locked
➜
Locked
May 29 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today